Cost-effectiveness of linezolid vs. vancomycin in nosocomial pneumonia due to suspected methicillin-resistant Staphylococcus aureus in France

被引：0
|
作者：
De Cock, E. [1 ]
Timsit, J. F. [2 ]
Carlet, J. [3 ]
Leroy, O. [4 ]
Wolff, M. [5 ]
Levrat, F. [6 ]
机构：
[1] United BioSource Corp, Barcelona, Spain
[2] Hop Albert Michallon, Grenoble, France
[3] Grp Hosp St Joseph, Paris, France
[4] Hop Guy, Tourcoing, France
[5] Hop Bichat Claude Bernard, F-75877 Paris 18, France
[6] Pfizer, Paris, France
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
    De Cock, E.
    Krueger, W. A.
    Sorensen, S.
    Baker, T.
    Hardewig, J.
    Duttagupta, S.
    Mueller, E.
    Piecyk, A.
    Reisinger, E.
    Resch, A.
    INFECTION, 2009, 37 (02) : 123 - 132
  • [2] Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany
    E. De Cock
    W. A. Krueger
    S. Sorensen
    T. Baker
    J. Hardewig
    S. Duttagupta
    E. Müller
    A. Piecyk
    E. Reisinger
    A. Resch
    Infection, 2009, 37
  • [3] Cost-effectiveness of linezolid versus vancomycin in suspected methicillin-resistant staphylococcus aureus in nosocomial pneumonia in Germany
    Grünewald, T
    De Cock, E
    Sorensen, SV
    Baker, TM
    Resch, A
    Hardewig, J
    Duttagupta, S
    VALUE IN HEALTH, 2004, 7 (06) : 758 - 758
  • [4] Cost-effectiveness of linezolid versus vancomycin in the treatment of nosocomial pneumonia suspected to be caused by methicillin-resistant Staphylococcus aureus in Spain
    Leon, C.
    Gomez, Mateos J. M.
    Catala, R.
    Vazquez, M. J.
    Alvarez, Rocha L.
    Najera, M. D.
    Rubio-Terres, C.
    Garcia, M.
    Escudero, Lopez-Cepero E.
    VALUE IN HEALTH, 2007, 10 (06) : A439 - A440
  • [5] Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Mullins, C. Daniel
    Kuznik, Andreas
    Shaya, Fadia T.
    Obeidat, Nour A.
    Levine, Andrew R.
    Liu, Larry Z.
    Wong, Winston
    CLINICAL THERAPEUTICS, 2006, 28 (08) : 1184 - 1198
  • [6] COST-EFFECTIVENESS OF LINEZOLID VS. VANCOMYCIN AND TEICOPLANIN IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS IN CZECH REPUBLIC
    Suchankova, E.
    Dolezal, T.
    Hajek, P.
    Kovar, P.
    VALUE IN HEALTH, 2009, 12 (07) : A422 - A422
  • [7] Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan
    Lin, Po-Chang
    Wang, Bruce C. M.
    Kim, Richard
    Magyar, Andrew
    Lai, Chung-Chih
    Yang, Ya-Wen
    Huang, Yhu-Chering
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (01) : 46 - 51
  • [8] LINEZOLID VS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA DUE TO METHICILLIN-RESISTANT S AUREUS
    Takada, Hiroaki
    Hifumi, Toru
    Koido, Yuichi
    Kuroda, Yasuhiro
    Kato, Hiroshi
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [9] Linezolid for the Treatment of Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
    Wolff, Michel
    Mourvillier, Bruno
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 160 - 161
  • [10] Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis Effectiveness of linezolid in the elderly
    Takada, Hiroaki
    Hifumi, Toru
    Nishimoto, Naoki
    Kanemura, Takashi
    Yoshioka, Hayato
    Okada, Ichiro
    Kiriu, Nobuaki
    Inoue, Junichi
    Koido, Yuichi
    Kato, Hiroshi
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2017, 35 (02): : 245 - 248
12345